CASE CLOSED … what really happened in the 2001 anthrax attacks?

* Here is a picture and identification of the regular attendees that Dr. Ayman Zawahiri sent Rauf Ahmad to infiltrate in connection with the annual anthrax conferences being held in England.

Posted by DXer on November 15, 2014

Screen shot 2014-11-15 at 5.09.07 AM



SOURCE: Proceedings of the International Workshop on Anthrax: Winchester, England, September 19-21, 1995

here is a slow-loading copy of that report online – the photo is about the first page after the main cover page …



2 Responses to “* Here is a picture and identification of the regular attendees that Dr. Ayman Zawahiri sent Rauf Ahmad to infiltrate in connection with the annual anthrax conferences being held in England.”

  1. DXer said

    The photo is from the 1995 conference — Dr. Ayman did not send his infiltrating scientist until the 1999 and 2000 conferences. Did he also send his scientist to the 2001 conference held in Maryland in June 2001?

    In a 2010 book, “Bioterror in the 21st Century: Emerging Threats in a New Global Environment,” someone reviewing the book that had been written by the current Undersecretary for Biosecurity at Homeland Security Department Dan Gersen noted:

    “In one scenario that Mr. Gerstein postulates, innocent biotechnical researchers are conned by terrorists posing as colleagues to give up secrets pertaining to peaceful purposes in order to speed the terrorists’ development of a very serious biological weapon.”

    God forbid Porton Down be embarrassed or that the FBI Special Agents miss out on the tea and cookies being served by Rauf Ahmad.

    FBI Overlooks Foreign Sources of Anthrax

    December 24, 2001

    by Edward Jay Epstein

    The security of the British anthrax bacteria is complicated by its privatization. In 1993, at the time it was supplying the virulent Ames strain sample, CAMR was partly privatized by the British government through a marketing agreement with Porton Products Ltd. in which Porton sold all its anthrax vaccine. Porton Products was owned by Speywood Holdings Ltd., which, in turn, was owned by I&F Holdings NV, a Netherlands Antilles corporate shell owned by Fuad El-Hibri, a Lebanese Arab with joint German-U.S. citizenship; his father, Ibrihim El-Hibri; and possibly other undisclosed investors.

    Prior to his taking over this biotech company, Fuad El-Hibri had worked in the mergers-and-acquisitions department of Citibank in Jedda, Saudi Arabia, where he specialized in arranging investments for large Saudi investors. Saudi Arabia then was interested in obtaining an anthrax vaccine to counter Saddam Hussein’s biological warfare capabilities. But the U.S. would not provide it.

    So when Mr. El-Hibri took over the British biotech lab, he reorganized its bio-terrorism defense business, and arranged deliveries of biotech defense products to Saudi Arabia. Mr. El-Hibri was unavailable for comment, but the ownership is a matter of record and he has not made a secret of his involvement in bio-warfare research. Indeed, he testified before Congress in 1999: “I participated in the marketing and distribution of substantial quantities of two bio-defense vaccines — botulinum Type A and anthrax.”

    Even more intriguing, Mr. El-Hibri’s interest in anthrax vaccines did not stop with his deal with CAMR. In 1998, he arranged a leveraged buyout of the Michigan Biological Products Institute. MBPI, which originally had been owned by the state of Michigan, held the exclusive contract for providing the U.S. government with anthrax vaccine. While its vaccine worked well against the Vollum strain of anthrax (used by Russia), it was more problematic against the Ames strain. So it had conducted tests with the virulent Ames strain on guinea pigs, mice and monkeys with mixed results. BioPort’s spokeperson confirmed that it had access to the virulent Ames strain for testing on animals. To take over MBPI, Mr. El-Hibri became an American citizen, and gave retired Adm. William J. Crowe Jr., a former chairman of the Joint Chiefs of Staff, a large block of stock in Intervac, one of the corporations involved in the maneuver. The controlling shareholder was the same I&F Holdings used to take control of the British biotech lab, CAMR. He then renamed the company BioPort. BioPort, which controlled America’s anthrax vaccine, was apparently of some interests to scientists in Afghanistan since an environmental assessment report of its planned laboratory renovations was turned up in the house of a Pakistani scientist in Kabul.

  2. DXer said

    Rauf Ahmad’s papers on the isolation of anthrax and the contamination of water were presented at the DANGEROUS PATHOGENS CONFERENCE 2000. Presentations were filmed.

    Mohammad Iqbal,* RaufAhmad,** A.S. Anjum*** and M.A. Baig * Quality Control, Ethical Laboratory, Lahore, Pakistan, **Biotechnology and Food
    Research Centre, PCSIR Labs, Complex, Lahore-54600, Pakistan, ***Veterinary Research Institute, Lahore Cantt, Pakistan

    A wild strain of Bacillusanthracis was isolated from a clinical case in order to establish a reference culture. The isolated strain was studied for its phenotypical as well biochemical properties. The tests were also conducted for the possession of fimbrae, flagella with motility, self agglutination and penicillin susceptibility. The subcutaneous injection of 100 spores of the isolated culture in to 16 gram mice resulted in death within 90 hrs. Thus, the findings were considered to be significant for the identification of wild strain of
    Bacillus anthracis.

    Another presentation by Rauf Ahmad’s involved the contamination of water.

    Rauf Ahmad,* Mohammad Iqbal,** A.S. Anjum*** and M.A.Baig *Biotechnology and Food Research Centre, PCSIR Labs, Complex, Lahore-54600, Pakistan, **Ethical Laboratory, Lahore, Paskistan, ***Veterinary Research Institute, Lahore Cantt, Pakistan

    Enteropathogenic Yersinia enterocoliticawas isolated from contaminated water by the traditional culture techniques. Water samples were filtered (Millipore) and filters were enriched over night in a Yersinia Selective enrichment broth and subsequently on Yersinia CIN agar at 370C for 24hrs. Complete study of the phenotypic and biochemical characteristics of the isolated strain was conducted. The characteristics of virulence such as autoagglutination at 370C, calcium dependent growth at 370C and uptake of Congo red dye were also studied. Finally the identification was carried out by a Latex agglutination test (Microgen) for the detection of enteropathogenic Yersinia enterocolitica (Myf).

    Film at 11.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: